AMGEN INC is 37.6x more valuable than CG Oncology, Inc. by market capitalization ($182.28 B vs $4.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CGON | AMGN |
|---|---|---|
| Market cap | $4.84 B | $182.28 B |
| US-listed rank | #1405 | #80 |
| Revenue (latest FY) | $4.04M | $36.75B |
| Net income (latest FY) | -$161.00M | $7.71B |
| Net margin | -3985.1% | 21.0% |
| P/E (trailing FY) | - | 23.6 |
| SEC filings | 189 | 1,011 |
AMGEN INC is 37.6x more valuable than CG Oncology, Inc. by market capitalization ($182.28 B vs $4.84 B).
In their latest fiscal years, CG Oncology, Inc. reported $4.04M in revenue while AMGEN INC reported $36.75B.
Full pages: CG Oncology, Inc. and AMGEN INC, or browse the full rankings.